Epidemiological Survey and Genetic Analysis of AD Patients in Hong Kong
Pilot Study: Epidemiological Survey and Genetic Analysis of Patients With Atopic Dermatitis in Hong Kong
1 other identifier
observational
450
1 country
1
Brief Summary
This is a joint research study between The Hong Kong Polytechnic University (PolyU) and The University of Hong Kong (HKU) as titled above. In view of the increasing prevalence of atopic dermatitis (AD), the lack of complete epidemiology data on childhood and adult AD in Hong Kong and the lack of complete understanding on the genetic and environmental factors associated with it, the purpose of this study to carry out an epidemiology and genetic study that targets AD patients within the local Hong Kong population. The investigators will search for new AD-associated genetic variants that are related to the local population and believe that the genetic profiles that arise from this project will form an important basis for the future management and treatment of AD, such as disease-risk screening strategy and therapeutic target development.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 12, 2019
CompletedFirst Submitted
Initial submission to the registry
October 29, 2019
CompletedFirst Posted
Study publicly available on registry
November 7, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedMay 5, 2022
May 1, 2022
2.5 years
October 29, 2019
May 4, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Significant SNPs
The significant single nucleotide polymorphisms (SNPs) between control group and different AD case subgroups (different age of onset, different AD severity, different relapsing status), Cochran-Armitage trend test will be used to assess statistical significance of the association with each SNP, and Mantel-Haenszel method for two 2 × 2 allele frequency tables will be used to assess association of SNPs on chromosome X within male and female subjects.
through study completion, an average of 1 year
Study Arms (2)
Atopic dermatitis group
Number of subjects in atopic dermatitis group 0 - \< 6 years : 50 subjects 6 - \<12 years : 50 subjects 12 - \<18 years : 50 subjects Adult (\>= 18 years) : 150 subjects Total no. of cases: 300 cases
Control group
\>= 40 yrs : 150 subjects
Eligibility Criteria
For AD cases: Chinese-Han AD subjects who was born in Hong Kong For Control: Chinese-Han subjects who was born in Hong Kong aged more or equal to 40 Years
You may qualify if:
- Normal controls (Recruited in Poly U)
- Aged more or equal to 40 \[Age of 40 is chosen as an arbitrary cutoff because studies had shown that the peak incidence among adult-onset AD cases occurs at age 20-40 years (Silvestre Salvador et al., 2017). Controls have been chosen more or equal to 40 years of age as they would likely have developed AD by the age of 40.
- Subjects that do not have a history of AD, personal history and family history of AD including first-, second-, and third-degree relatives;
- Subjects without a personal history and/or family history of other allergic and atopic disorders such as autoimmune diseases, skin disorders and systemic diseases.
- Born in Hong Kong and Chinese-Han
- AD cases (Recruited from QMH and TWH)
- Patients have to be clinically diagnosed by a qualified dermatologist on the basis of a skin examination diagnosed according to Hanifin and Rajka criteria.
- Children cases should be aged \< 18 at the time of recruitment and adult cases should be aged 18 at the time of recruitment;
- Born in Hong Kong and Chinese-Han
You may not qualify if:
- Non-Chinese or non-local case and control subjects;
- Either of the parents are non-Chinese;
- Case and control subjects who do not speak or understand Cantonese or Chinese;
- Age \<40 for control subjects;
- Subjects who are pregnant;
- Unable to provide signed informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The University of Hong Konglead
- The Hong Kong Polytechnic Universitycollaborator
Study Sites (1)
Department of Medicine
Central, Hong Kong
Biospecimen
Blood sample in K2EDTA and SST tubes and/or buccal swab
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mandy Chan, MBBS
The University of Hong Kong
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Assistant Professor
Study Record Dates
First Submitted
October 29, 2019
First Posted
November 7, 2019
Study Start
July 12, 2019
Primary Completion
December 31, 2021
Study Completion
June 30, 2022
Last Updated
May 5, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share
No plan to share individual participant data